Omzet 2024 * | 46,24 mld. 49,76 mld. | Omzet 2025 * | 49,92 mld. 53,72 mld. | Marktkapitalisatie | 114 mld. 123 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 7,13 mld. 7,67 mld. | Nettowinst (verlies) 2025 * | 8,66 mld. 9,32 mld. | EV/omzet 2024 * | 2,61 x |
Nettoschuld 2024 * | 6,56 mld. 7,06 mld. | Nettoschuld 2025 * | 1,95 mld. 2,1 mld. | EV/omzet 2025 * | 2,32 x |
K/w-verhouding 2024 * |
16,1
x | K/w-verhouding 2025 * |
13,2
x | Werknemers | - |
Dividendrendement 2024 * |
4,21% | Dividendrendement 2025 * |
4,46% | Vrij verhandelbaar | 87,12% |
Recentste transcriptie over Sanofi SA
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Hudson
CEO | Chief Executive Officer | 56 | 01-09-19 |
Madeleine Roach
COO | Chief Operating Officer | 40 | 01-01-22 |
Chief Tech/Sci/R&D Officer | 51 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Patrick Kron
BRD | Director/Board Member | 70 | 01-05-14 |
Gilles Schnepp
BRD | Director/Board Member | 64 | 22-05-20 |
Frédéric Oudéa
CHM | Chairman | 60 | 02-09-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,08% | 662 mld. | |
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-11,12% | 194 mld. | |
+8,08% | 167 mld. |